Placental anticoagulant protein-l: Measurement in extracellular fluids and cells of the hemostatic system

M. J. Flaherty, S. West, R. L. Heimark, K. Fujikawa, J. F. Tait

Research output: Contribution to journalArticlepeer-review

106 Scopus citations


Placental anticoagulant protein-l (PAP-l), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-l were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-l was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 ± 20 ng/ml). Gel filtration experiments showed that PAP-l was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 ± 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 ± 109 ng/mg in platelets; 564 ± 384 ng/mg in leukocytes; and 8.4 ± 4.3 ng/mg in erythrocytes. The levels of PAP-l increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-l probably does not function as a circulating natural anticoagulant in normal persons.

Original languageEnglish (US)
Pages (from-to)174-181
Number of pages8
JournalJournal of Laboratory and Clinical Medicine
Issue number2
StatePublished - 1990
Externally publishedYes

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Placental anticoagulant protein-l: Measurement in extracellular fluids and cells of the hemostatic system'. Together they form a unique fingerprint.

Cite this